Clinical Trials Logo

Lung Cancer Stage II clinical trials

View clinical trials related to Lung Cancer Stage II.

Filter by:

NCT ID: NCT03290534 Recruiting - Lung Cancer Clinical Trials

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

Start date: March 13, 2019
Phase: Phase 2
Study type: Interventional

This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical structures, such as the heart wall, while giving a therapeutic dose to diseased tissue, such as at a surgical margin.

NCT ID: NCT03141359 Active, not recruiting - Clinical trials for Non Small Cell Lung Cancer

Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC

Start date: May 12, 2017
Phase: Phase 2
Study type: Interventional

This is a single-arm, single-stage Phase II study designed to evaluate the 1-year PFS rate in subjects with locally-advanced NSCLC (stage II/III) and treated with Stereotactic Body Radiation Therapy (SBRT) followed by concurrent mediastinal chemoradiation with or without consolidation chemotherapy. A total of 60 subjects will be enrolled to this study over a 4 year accrual period.